Pistel K F, Bittner B, Koll H, Winter G, Kissel T
Department of Pharmaceutics and Biopharmacy, Philipps-University, Marburg, Germany.
J Control Release. 1999 Jun 2;59(3):309-25. doi: 10.1016/s0168-3659(99)00008-5.
Recombinant human erythropoietin (EPO) and fluorescein isothiocyanate labeled dextran (FITC-dextran) loaded microspheres were prepared by a modified W/O/W double-emulsion technique. Biodegradable linear ABA block copolymers consisting of poly(L-lactide-co-glycolide) A blocks attached to central poly(ethyleneoxide) (PEO) B blocks and star-branched AB block copolymers containing A blocks of poly(L-lactide) or poly(L-lactide-co-glycolide) and star-branched poly(ethyleneoxide) B blocks were investigated for their potential as sustained release drug delivery systems. Microsphere characteristics were strongly influenced by the polymer composition. In the case of the linear block copolymers, a reduced lactic acid content in a linear block copolymer yielded smaller particles, a lower encapsulation efficiency, and a higher initial drug release both in the case of EPO and FITC-dextran. The investigation of the effects of several manufacturing parameters on microsphere formation showed that the process temperature plays an important role. Microsphere formation in a +1 degrees C environment resulted in higher drug loadings without increasing the amount of residual dichloromethane inside the particles. Other parameters such as the homogenization of the primary W/O emulsion and of the W/O/W double-emulsion have less impact on microsphere characteristics. Branched block copolymers containing star-shaped PEO also showed potential for the preparation of drug loaded microspheres. A certain amount of glycolic acid in the copolymer was necessary for the successful preparation of non-aggregating microspheres at room temperature. Again, the processing temperature strongly affected particle characteristics. Microsphere preparation at +1 degrees C allows the formation of microspheres from a polymer not containing glycolic acid, a result which could not be achieved at room temperature. Moreover, compared to microsphere formation at room temperature, the effective FITC-dextran loading was increased. Concerning the EPO loaded microspheres, the amount of EPO aggregated was comparable to that using the linear ABA polymers. A continuous release of the protein from these star-shaped polymers could not be achieved. In conclusion, apart from microsphere preparation in a +1 degrees C environment the choice of the polymer represents the main factor for a successful entrapment of proteins into biodegradable microspheres.
采用改良的W/O/W双乳液技术制备了负载重组人促红细胞生成素(EPO)和异硫氰酸荧光素标记葡聚糖(FITC-葡聚糖)的微球。研究了由连接到中心聚环氧乙烷(PEO)B嵌段上的聚(L-丙交酯-共-乙交酯)A嵌段组成的可生物降解线性ABA嵌段共聚物以及含有聚(L-丙交酯)或聚(L-丙交酯-共-乙交酯)A嵌段和星形支化聚环氧乙烷B嵌段的星形支化AB嵌段共聚物作为缓释药物递送系统的潜力。微球特性受聚合物组成的强烈影响。对于线性嵌段共聚物,线性嵌段共聚物中乳酸含量降低会产生更小的颗粒、更低的包封效率以及在EPO和FITC-葡聚糖两种情况下更高的初始药物释放率。对几种制造参数对微球形成的影响进行研究表明,工艺温度起着重要作用。在+1℃环境中形成微球可实现更高的药物负载量,且不会增加颗粒内部残留二氯甲烷的量。其他参数,如初级W/O乳液和W/O/W双乳液的均化对微球特性的影响较小。含有星形PEO的支化嵌段共聚物在制备载药微球方面也显示出潜力。共聚物中一定量的乙醇酸对于在室温下成功制备不聚集的微球是必要的。同样,加工温度强烈影响颗粒特性。在+1℃下制备微球能够由不含乙醇酸的聚合物形成微球,这一结果在室温下无法实现。此外,与在室温下形成微球相比,有效FITC-葡聚糖负载量增加。对于负载EPO的微球,聚集的EPO量与使用线性ABA聚合物时相当。无法实现蛋白质从这些星形聚合物中的持续释放。总之,除了在+1℃环境中制备微球外,聚合物的选择是将蛋白质成功包封到可生物降解微球中的主要因素。